Clinical Trials in Texas

Showing 6761-6780 of 11,487 trials

Study of a Prebiotic Supplement to Mitigate Excessive Weight Gain Among Physicians in Residency

NCT04498455

A randomized placebo controlled trial to determine if increased dietary fiber will prevent weight gain, inhibit adiposity and reduce perceived stress levels in residents at the Waco Family Health Center as the result of changes in distal gut microbiota composition and function.

Weight Gain TrajectoryMetabolic Syndrome

Baylor University11 participantsStarted Sep 2018

Waco, Texas, United States

COMPLETEDPhase 355 miles

Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years With Major Depressive Disorder (MDD)

NCT02709746

Evaluating the efficacy of vortioxetine 10 mg/day and 20 mg/day versus placebo on depressive symptoms in adolescents (age ≥12 and ≤17 years) with a DSM-5™ (Diagnostic and Statistical Manual of Mental Disorders, 5th edition) diagnosis of Major depressive disorder (MDD).

Depressive Disorder, Major

H. Lundbeck A/S784 participantsStarted May 2016

Dothan, Alabama, United States • Tucson, Arizona, United States • Little Rock, Arkansas, United States +121 more locations

Study of a Prebiotic Supplement to Mitigate Excessive Weight Gain Among Physicians in Residency

Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years With Major Depressive Disorder (MDD)

Find Trials by Condition in Texas

Blood Sample Collection to Evaluate Biomarkers for Hepatocellular Carcinoma

Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors

Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer

Safety Study on Stopping Anticoagulation Medication in Patients With a History of Atrial Fibrillation

Prospective Multicenter Trial to Compare Preformed vs Non Preformed Orbital Implants

Safety and Efficacy of a Lysophosphatidic Acid Receptor Antagonist in Idiopathic Pulmonary Fibrosis

Study of MLN2480 in Participants With Relapsed or Refractory Solid Tumors Followed by a Dose Expansion in Participants With Metastatic Melanoma

A Study to Assess the Efficacy and Safety of Abatacept in Adults With Active Primary Sjögrens Syndrome

A Safety Study of NNZ-2566 in Pediatric Rett Syndrome

Expanded Access: Mino-Lok Therapy (MLT) for the Treatment of CRBSI/CLABSI

Bortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin Lymphoma

A Rollover Safety Study of Lumacaftor/Ivacaftor in Subjects Aged 2 Years and Older With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation

Efficacy and Safety of Intravenous Neridronic Acid in CRPS

Efficacy and Safety of Intravenous Neridronic Acid in Complex Regional Pain Syndrome (CRPS)

Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)

A Study of Baricitinib (LY3009104) in Patients With Moderate to Severe Atopic Dermatitis

Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment

Study of the Safety, Pharmacodynamics, Efficacy, and PK of TIMP-GLIA in Subjects With Celiac Disease